Argonne’s life sciences research has yielded a portfolio of advanced technologies that are having a profound impact on medical technologies and therapies, energy production and sustainability, and bioremediation.
Argonne’s roster of world-class biology and environmental scientists develop viable technologies — from cancer therapies and antibody engineering to biological methane production and engineered biofuels — that are based on a solid foundation of basic research.
Argonne works with existing and start-up businesses to license our patented life sciences technologies and to develop, analyze, and test bio-based new and emerging technologies.